Financhill
Sell
22

CNNA Quote, Financials, Valuation and Earnings

Last price:
$0.0009
Seasonality move :
-8.24%
Day range:
$0.0009 - $0.0009
52-week range:
$0.0000 - $0.0240
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.00x
Volume:
--
Avg. volume:
199.6K
1-year change:
-68.97%
Market cap:
--
Revenue:
--
EPS (TTM):
--

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Cann American Corp. has -- downside to fair value with a price target of -- per share.

CNNA vs. S&P 500

  • Over the past 5 trading days, Cann American Corp. has underperformed the S&P 500 by -1.41% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Cann American Corp. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Cann American Corp. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Cann American Corp. reported revenues of --.

Earnings Growth

  • Cann American Corp. has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Cann American Corp. reported earnings per share of --.
Enterprise value:
235.8K
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-0.59x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2010-08-31 2011-08-31 2012-08-31 2011-08-31 2012-08-31
Income Statement
Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
Operating Income -$28.3K -$543.4K -$1.8M -$214.3K -$87.6K
EBITDA -$28.3K -$543.4K -$1.8M -$214.3K -$87.6K
Diluted EPS -- -$0.08 -$0.64 -- --
Period Ending 2008-08-31 2009-08-31 2010-08-31 2011-08-31 2012-08-31
Balance Sheet
Current Assets -- $300 $10 $10.1K $4.9K
Total Assets -- $300 $10 $1.2M $921.9K
Current Liabilities -- $10K $33.5K $9.9K $281.2K
Total Liabilities -- $10K $33.5K $70.4K $281.2K
Total Equity -- -$9.7K -$33.5K $1.1M $640.6K
Total Debt -- -- -- $60.5K $176K
Trailing 12 Months Fiscal Quarters
Period Ending 2010-08-31 2011-08-31 2012-08-31 2011-08-31 2012-08-31
Cash Flow Statement
Cash Flow Operations -$12.3K -$92.4K -$299.5K -$7.7K -$52.7K
Cash From Investing -$500 -- -- -- --
Cash From Financing $12.5K $92.5K $299.2K -- $41.6K
Free Cash Flow -$12.3K -$92.4K -$299.5K -$7.6K -$52.7K
CNNA
Sector
Market Cap
--
--
Price % of 52-Week High
3.75%
--
Dividend Yield
0%
--
Shareholder Yield
--
--
1-Year Price Total Return
-68.97%
--
Beta (5-Year)
-0.718
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $0.0012
200-day SMA
Sell
Level $0.0028
Bollinger Bands (100)
Sell
Level 0.0022 - 0.0022
Chaikin Money Flow
Buy
Level 5.5M
20-day SMA
Sell
Level $0.0015
Relative Strength Index (RSI14)
Sell
Level 40.0855
ADX Line
Sell
Level 32.8472
Williams %R
Neutral
Level -60
50-day SMA
Sell
Level $0.0020
MACD (12, 26)
Sell
Level -0.0002
25-day Aroon Oscillator
Sell
Level -16
On Balance Volume
Sell
Level -442.5K

Financial Scores

--
Altman Z-Score (Annual)
Level (--)
--
CA Score (Annual)
Level (--)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (2)
--
Ohlson Score
Level (--)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Cann American Corp. engages in the provision of hemp-based cannabidiol supplements for dogs, cats, and horses. The company was founded on August 25, 2004 and is headquartered in Rutherford, NJ.

Stock Forecast FAQ

In the current month, CNNA has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CNNA average analyst price target in the past 3 months is --.

  • Where Will Cann American Corp. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Cann American Corp. share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Cann American Corp.?

    Analysts are divided on their view about Cann American Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cann American Corp. is a Sell and believe this share price will rise from its current level to --.

  • What Is Cann American Corp.'s Price Target?

    The price target for Cann American Corp. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is CNNA A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Cann American Corp. is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of CNNA?

    You can purchase shares of Cann American Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cann American Corp. shares.

  • What Is The Cann American Corp. Share Price Today?

    Cann American Corp. was last trading at $0.0009 per share. This represents the most recent stock quote for Cann American Corp.. Yesterday, Cann American Corp. closed at $0.0009 per share.

  • How To Buy Cann American Corp. Stock Online?

    In order to purchase Cann American Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock